The predictors of overall survival time after surgical treatment in non-small cell lung cancer

  • Trần Minh Bảo Luân Trường Đại học Y Dược Thành phố Hồ Chí Minh
  • Vũ Trí Thanh Trường Đại học Y Dược Thành phố Hồ Chí Minh

Main Article Content

Keywords

Video-Assited Thoracoscopic Surgery (VATS), lobectomy and lymphadenectomy

Abstract

Objective: To identify the prognostic factors in non-small cell lung cancer treated by combination surgery and adjuvant chemo-radiotherapy. Subject and method: Prospective, longitudinal description, 109 cases of primary non-small cell lung cancer were treated by VATS lobectomy and lymphadenectomy at University Medical Center Ho Chi Minh city and Pham Ngoc Thach Hospital from 01/01/2012 to 31/12/2016. Result: Total survival time was 46.9 ± 1.9 months (13 - 60 months); 100% survival rate in the first year; after 2 years 85.9%, after 3 years 65.3% and 5 year overall survival rate 55.9%. The postoperative stage of lung cancer and the ability of radical lymphadenectomy were significant factors in survival (p=0.001). In addition, the number of metastatic nodules, lymph node size (p<0.001), tumor size and tumor differentiation (p<0.05) were also predictors. Conclusion: Stage of lung cancer, surgical removal of radical lymph nodes, number of metastatic lymph nodes, size of lymph nodes, tumor differentiation and tumor size are predictive factors of postoperative survival in non-small cell lung cancer.

Article Details

References

1. Vũ Anh Hải, Phạm Vinh Quang, Mai Văn Viện (2016) Đánh giá kết quả phẫu thuật nội soi lồng ngực hỗ trợ cắt thùy phổi điều trị ung thư phổi. Tạp chí Y - Dược học Quân sự, 41(2), tr. 142-149.
2. Nguyễn Khắc Kiểm (2016) Nghiên cứu nạo vét hạch theo bản đồ trong phẫu thuật điều trị ung thư phổi không tế bào nhỏ giai đoạn I - II - IIIA. Luận án tiến sỹ Y học. Đại học Y Hà Nội.
3. Barletta JA et al (2010) The Prognostic significance of grading in lung adenocarcinoma. Cancer 116(3): 659-669. doi: 10.1002/cncr.24831.
4. Cerfolio RJ et al (2017) The long-term survival of robotic lobectomy for non small cell lung cancer: A multi-institutional study.
https://doi.org/10.1016/j.jtcvs.2017.09.016
5. Lim E, Baldwin D, Beckles M et al (2010) Guidelines on the radical management of patients with lung cance. Thorax 65(3): 1- 27.
6. Prenzel KL et al (2013) Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest 123: 453-467.
7. Shields TW, LoCicero J et al (2009) Lung cancer. surgical treatment of non-small-cell lung cancer. In General Thoracic Surgery 7: 1388-13425.
8. Wenlong S et al (2014) Safety and feasibility of video-assisted thoracoscopic surgery for stage IIIA lung cancer. Chin J Cancer Res 26(4): 418-422.
9. Wu Y, Hauang ZF, Wang SY et al (2012) A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 36: 1-6.
10. Zhang J et al (2015) Relationship between tumor size and survival in non-small cell lung cancer (NSCLC): An analysis of the Surveillance, Epidemiology, and End Results (SEER) registry. J Thorac Oncol 10(4): 682-690.